Cryolipolysis for fat reduction using Cooltech® Define technology: A large‐sample retrospective clinical study

Author:

Vignoli Fabrizio1,Mármol Gregorio Viera2

Affiliation:

1. Studio Vignoli Bologna Italy

2. Sinclair ‐ High Technology Products SLU Barcelona Spain

Abstract

AbstractBackgroundCryolipolysis is a noninvasive technique for localized fat reduction, which induces selective apoptosis of the adipocytes using controlled exposure to intense cold. During the past 10 years, this technique has been shown to be safe and effective and its application has significantly increased. In this context, Cooltech® devices have been widely used around the world.AimsThe purpose of this retrospective study was to evaluate the efficacy and safety of the removal of localized fatty tissue in different body areas using the new Cooltech® Define controlled cooling system.MethodsThis single‐center study was carried out on 287 patients, both female and male, treated with Cooltech® Define on different body areas for a total of 1118 procedures. Follow‐up evaluations were conducted to estimate efficacy and safety. Efficacy was evaluated through plicometry and photographs. Side effects were also reported.ResultsFold thickness showed a significant reduction (−69.91 ± 12.55%) after cryolipolysis treatment (fold thickness before: 35.33 ± 8.41 mm; fold thickness after: 10.69 ± 5.27 mm). Few side effects were reported, they included posttreatment pain (1.70%) and one case of paradoxical adipose hyperplasia (0.09%).ConclusionThe Cooltech® Define cryolipolysis device is a safe, effective, and well‐tolerated nonsurgical procedure for reducing localized fat.

Publisher

Wiley

Subject

Dermatology

Reference22 articles.

1. Non-invasive subcutaneous fat reduction: a review

2. Cryolipolysis—An update

3. The Safety and Efficacy of Cryolipolysis: A Systematic Review of Available Literature

4. Longitudinal evaluation of cryolipolysis efficacy: two case studies

5. US Food and Drug Administration 510(k) clearance K080521.2010. Accessed August 1 2023. Available from:https://www.accessdata.fda.gov/cdrh_docs/pdf8/K080521.pdf

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3